New dual inhibitors of bacterial topoisomerases with broad-spectrum antibacterial activity and In vivo efficacy against vancomycin - intermediate Staphylococcus aureus
Povzetek
A new series of dual low nanomolar benzothiazole inhibitors of bacterial DNA gyrase and topoisomerase IV were developed. The resulting compounds show excellent broad-spectrum antibacterial activities against Gram-positive Enterococcus faecalis, Enterococcus faecium and multidrug resistant (MDR) Staphylococcus aureus strains [best compound minimal inhibitory concentrations (MICs): range, <0.03125–0.25 μg/mL] and against the Gram-negatives Acinetobacter baumannii and Klebsiella pneumoniae (best compound MICs: range, 1–4 μg/mL). Lead compound 7a was identified with favorable solubility and plasma protein binding, good metabolic stability, selectivity for bacterial topoisomerases, and no toxicity issues. The crystal structure of 7a in complex with Pseudomonas aeruginosa GyrB24 revealed its binding mode at the ATP-binding site. Expanded profiling of 7a and 7h showed potent antibacterial activity against over 100 MDR and non-MDR strains of A. baumannii and several other Gram-positive and Gram-negative strains. Ultimately, in vivo efficacy of 7a in a mouse model of vancomycin-intermediate S. aureus thigh infection was also demonstrated.
Ključne besede
antibacterial activity;bacteria;inhibitors;
Podatki
| Jezik: | Angleški jezik |
|---|---|
| Leto izida: | 2023 |
| Tipologija: | 1.01 - Izvirni znanstveni članek |
| Organizacija: | UL FFA - Fakulteta za farmacijo |
| UDK: | 615.015.8 |
| COBISS: |
144333571
|
| ISSN: | 1520-4804 |
| Št. ogledov: | 53 |
| Št. prenosov: | 19 |
| Ocena: | 0 (0 glasov) |
| Metapodatki: |
|
Ostali podatki
| Sekundarni jezik: | Slovenski jezik |
|---|---|
| Sekundarne ključne besede: | antibakterijsko delovanje;zaviralci;nanomolarni inhibitorji benzotiazola;topoizomeraza IV;Farmacevtska kemija;Bakterije;Bakterijska rezistenca; |
| Vrsta dela (COBISS): | Članek v reviji |
| Strani: | str. 3968-3994 |
| Letnik: | ǂVol. ǂ66 |
| Zvezek: | ǂiss. ǂ6 |
| Čas izdaje: | 2023 |
| DOI: | 10.1021/acs.jmedchem.2c01905 |
| ID: | 18498164 |
Priporočena dela:
New dual inhibitors of bacterial topoisomerases with broad-spectrum antibacterial activity and In vivo efficacy against vancomycin - intermediate Staphylococcus aureus
2023,
ni podatka o podnaslovu
Discovery and Hit-to-Lead Optimization of Benzothiazole scaffold-based DNA gyrase inhibitors with potent activity against Acinetobacter baumannii and Pseudomonas aeruginosa
2023,
ni podatka o podnaslovu
Next-generation heterocyclic electrophiles as small-molecule covalent MurA inhibitors
2022,
ni podatka o podnaslovu
Amide containing NBTI antibacterials with reduced hERG inhibition, retained antimicrobial activity against gram-positive bacteria and in vivo efficacy
2023,
ni podatka o podnaslovu
Vrednotenje dvojnih zaviralcev bakterijskih topoizomeraz
2020,
ni podatka o podnaslovu